Forge’s Piteri-Molina on AI, Ohio and what’s next for gene therapy manufacturing

The BioSpace 40 Under 40 honoree helped steer Forge’s sale to Ajinomoto. Now, Samantha Piteri-Molina sees opportunities in AI-driven analytics and Ohio’s gene therapy ecosystem—with a responsibility to patients worldwide.

Samantha Piteri-Molina, a BioSpace 40 Under 40 honoree, played a key role in steering the sale of Forge to Ajinomoto.

Piteri-Molina now sees potential in AI-driven analytics for gene therapy manufacturing, as well as Ohio's growing gene therapy ecosystem.

She emphasizes the importance of considering patients worldwide in the development and manufacturing of gene therapies.